ZhongHua Southern Pharma Sdn. Bhd. was established in Penang on September 2014 and one of the subsidiary company from China National Traditional Chinese Medicine Corporation. Sino-Pharma is directly managed by State-owned Assets Supervision and Administration Commission of the State Council (SASAC), has largest scale with exhaustive industrial chain, is the most comprehensive medical and health industry group. By prioritizing public health, Sino-Pharma involve itself in R&D, production, distribution and retail of health related products such as preventive, treatment and nursing diagnostic. Sino-Pharma is the only medical and health rganization that succeed being listed in Fortune 500, currently at 194th place (2018).ZhongHua Southern Pharma is based on China "one belt, one road" slogan, promoting "going out" of the Chinese medicine industry. Based on the industry, it integrated the resources of Southeast Asian Chinese medicine, including the development of frankincense, myrrh, bird's nest, durian, clove, and agarwood. We import resources, comprehensively creating “ZhongHua” brands. With the strategic positioning of “prominent specialization, diversification and regionalization”, ZhongHua Southern Pharma adheres to corporate philosophy of “care for life and care for health”, inherits and promotes development.
ZhongHua Southern Pharma Sdn. Bhd. was established in Penang on September 2014 and one of the subsidiary company from China National Traditional Chinese Medicine Corporation. Sino-Pharma is directly managed by State-owned Assets Supervision and Administration Commission of the State Council (SASAC), has largest scale with exhaustive industrial chain, is the most comprehensive medical and health industry group. By prioritizing public health, Sino-Pharma involve itself in R&D, production, distribution and retail of health related products such as preventive, treatment and nursing diagnostic. Sino-Pharma is the only medical and health rganization that succeed being listed in Fortune 500, currently at 194th place (2018).ZhongHua Southern Pharma is based on China "one belt, one road" slogan, promoting "going out" of the Chinese medicine industry. Based on the industry, it integrated the resources of Southeast Asian Chinese medicine, including the development of frankincense, myrrh, bird's nest, durian, clove, and agarwood. We import resources, comprehensively creating “ZhongHua” brands. With the strategic positioning of “prominent specialization, diversification and regionalization”, ZhongHua Southern Pharma adheres to corporate philosophy of “care for life and care for health”, inherits and promotes development.
ZhongHua Southern Pharma Sdn. Bhd. was established in Penang on September 2014 and one of the subsidiary company from China National Traditional Chinese Medicine Corporation. Sino-Pharma is directly managed by State-owned Assets Supervision and Administration Commission of the State Council (SASAC), has largest scale with exhaustive industrial chain, is the most comprehensive medical and health industry group. By prioritizing public health, Sino-Pharma involve itself in R&D, production, distribution and retail of health related products such as preventive, treatment and nursing diagnostic. Sino-Pharma is the only medical and health rganization that succeed being listed in Fortune 500, currently at 194th place (2018).ZhongHua Southern Pharma is based on China "one belt, one road" slogan, promoting "going out" of the Chinese medicine industry. Based on the industry, it integrated the resources of Southeast Asian Chinese medicine, including the development of frankincense, myrrh, bird's nest, durian, clove, and agarwood. We import resources, comprehensively creating “ZhongHua” brands. With the strategic positioning of “prominent specialization, diversification and regionalization”, ZhongHua Southern Pharma adheres to corporate philosophy of “care for life and care for health”, inherits and promotes development.